Literature DB >> 16122672

Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis.

Tihana Bicanic, Robin Wood, Linda-Gail Bekker, Marta Darder, Graeme Meintjes, Thomas S Harrison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16122672     DOI： 10.1016/S1473-3099(05)70197-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  18 in total

Review 1.  Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence.

Authors:  Jim Kronstad; Sanjay Saikia; Erik David Nielson; Matthias Kretschmer; Wonhee Jung; Guanggan Hu; Jennifer M H Geddes; Emma J Griffiths; Jaehyuk Choi; Brigitte Cadieux; Mélissa Caza; Rodgoun Attarian
Journal:  Eukaryot Cell       Date:  2011-12-02

2.  Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.

Authors:  Nelesh P Govender; Jaymati Patel; Marelize van Wyk; Tom M Chiller; Shawn R Lockhart
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

Review 3.  Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis.

Authors:  Gunjan Gupta; Bettina C Fries
Journal:  Future Microbiol       Date:  2010-05       Impact factor: 3.165

4.  Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.

Authors:  Gloria M González; Néstor Casillas-Vega; Elvira Garza-González; Romel Hernández-Bello; Gildardo Rivera; Jesús Ancer Rodríguez; Virgilio Bocanegra-Garcia
Journal:  Folia Microbiol (Praha)       Date:  2015-06-25       Impact factor: 2.099

Review 5.  Physiological Differences in Cryptococcus neoformans Strains In Vitro versus In Vivo and Their Effects on Antifungal Susceptibility.

Authors:  Nina T Grossman; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

6.  The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest.

Authors:  Karen H Bartlett; Sarah E Kidd; James W Kronstad
Journal:  Curr Infect Dis Rep       Date:  2008-03       Impact factor: 3.725

7.  Cryptococcus neoformans phosphoinositide-dependent kinase 1 (PDK1) ortholog is required for stress tolerance and survival in murine phagocytes.

Authors:  Yeissa Chabrier-Roselló; Kimberly J Gerik; Kristy Koselny; Louis DiDone; Jennifer K Lodge; Damian J Krysan
Journal:  Eukaryot Cell       Date:  2012-10-19

8.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.

Authors:  M A Pfaller; D J Diekema; D L Gibbs; V A Newell; H Bijie; D Dzierzanowska; N N Klimko; V Letscher-Bru; M Lisalova; K Muehlethaler; C Rennison; M Zaidi
Journal:  J Clin Microbiol       Date:  2008-11-12       Impact factor: 5.948

9.  The cAMP/Protein Kinase A Pathway and Virulence in Cryptococcus neoformans.

Authors:  James W Kronstad; Guanggan Hu; Jaehyuk Choi
Journal:  Mycobiology       Date:  2011-09-27       Impact factor: 1.858

Review 10.  Treatment of cryptococcal meningitis in resource limited settings.

Authors:  Derek J Sloan; Martin J Dedicoat; David G Lalloo
Journal:  Curr Opin Infect Dis       Date:  2009-10       Impact factor: 4.915
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.